Log in to your Inderes Free account to see all free content on this page.
AlzeCure Pharma
1.215
SEK
-3.95 %
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
-3.95%
+15.71%
-39.1%
-35.2%
-58.57%
-59.61%
-76.05%
-67.72%
-87.81%
AlzeCure Pharma is a pharmaceutical company. The company focuses on research and development of drugs used for various brain diseases, with the greatest focus on Alzheimer's disease, but also on pain. The technology and research is based on its own pharmaceutical platform, where the company develops various symptom-relieving and disease-modifying drug candidates. The head office is in Huddinge.
Read moreMarket cap
107.28M SEK
Turnover
21.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
27.2.
2025
Annual report '24
5.5.
2025
Interim report Q1'25
14.5.
2025
General meeting '24
ShowingAll content types
AlzeCure Pharma to present at Redeye Life Science Day on December 3
AlzeCure Pharma to present at Stora Aktiedagarna in Stockholm
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio